Alex Ward (Menlo Park) joined KKR in 2020 and is a member of the Healthcare industry team within the firm’s Americas Private Equity platform. He currently serves on the Board of Directors of Cotiviti, Heartland Dental, 123Dentist, Therapy Brands, and BlueSprig Pediatrics and is involved in the firm’s investments in Argenta and Asclepius. He was formerly involved with Global Medical Response. Prior to joining KKR, Mr. Ward was with Hellman & Friedman, where he spent time evaluating businesses in healthcare, consumer & retail, and software, and previously worked at Bain & Company. Mr. Ward holds a B.A. in Global Affairs and Economics from Yale University.